Home NDC 72912-525-30 ADHANSIA XR
Product NDC 72912-525
Requested package NDC 72912-525-30
11-digit product format 729120525
Labeler code 72912
Product ID 72912-525_d5202e47-4f6c-423a-8f94-a8a5402da896
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name methylphenidate hydrochloride
Dosage form CAPSULE, EXTENDED RELEASE
Route ORAL
Labeler Adlon Therapeutics L.P.
Application NDA212038
Marketing category NDA
Marketing start 2019-07-01
Marketing end 2023-11-01
Substance METHYLPHENIDATE HYDROCHLORIDE
Active strength 25 mg/1
Pharmacologic classes Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
DEA schedule CII
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212038-001 ADHANSIA XR METHYLPHENIDATE HYDROCHLORIDE 25MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 N212038-002 ADHANSIA XR METHYLPHENIDATE HYDROCHLORIDE 35MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 N212038-003 ADHANSIA XR METHYLPHENIDATE HYDROCHLORIDE 45MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 N212038-004 ADHANSIA XR METHYLPHENIDATE HYDROCHLORIDE 55MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 N212038-005 ADHANSIA XR METHYLPHENIDATE HYDROCHLORIDE 70MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 N212038-006 ADHANSIA XR METHYLPHENIDATE HYDROCHLORIDE 85MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27
Orange Book patents# Current patent rows page 1 of 1 · 72 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 258 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N212038-001 ADHANSIA XR 25MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 ADHANSIA XR 35MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 ADHANSIA XR 45MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-004 ADHANSIA XR 55MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-005 ADHANSIA XR 70MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-006 ADHANSIA XR 85MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212038-001 ADHANSIA XR 25MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212038-002 ADHANSIA XR 35MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212038-003 ADHANSIA XR 45MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212038-004 ADHANSIA XR 55MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212038-005 ADHANSIA XR 70MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212038-006 ADHANSIA XR 85MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212038-001 ADHANSIA XR 25MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212038-002 ADHANSIA XR 35MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212038-003 ADHANSIA XR 45MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212038-004 ADHANSIA XR 55MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212038-005 ADHANSIA XR 70MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212038-006 ADHANSIA XR 85MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212038-001 ADHANSIA XR 25MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212038-002 ADHANSIA XR 35MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212038-003 ADHANSIA XR 45MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212038-004 ADHANSIA XR 55MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212038-005 ADHANSIA XR 70MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212038-006 ADHANSIA XR 85MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212038-001 ADHANSIA XR 25MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212038-002 ADHANSIA XR 35MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212038-003 ADHANSIA XR 45MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212038-004 ADHANSIA XR 55MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212038-005 ADHANSIA XR 70MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212038-006 ADHANSIA XR 85MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212038-001 ADHANSIA XR 25MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212038-002 ADHANSIA XR 35MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212038-003 ADHANSIA XR 45MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212038-004 ADHANSIA XR 55MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212038-005 ADHANSIA XR 70MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212038-006 ADHANSIA XR 85MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212038-001 ADHANSIA XR 25MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212038-002 ADHANSIA XR 35MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212038-003 ADHANSIA XR 45MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212038-004 ADHANSIA XR 55MG CAPSULE, EXTENDED RELEASE / ORAL RLD 2019-02-27 b8a1b40f171c…
Observed Orange Book patent history# Patent history page 1 of 73 · 2,916 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N212038-001 10111839 2035-10-30 U-2357 2019-03-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10292938 2035-10-30 Drug product 2019-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10292939 2035-10-30 U-2357 Drug product 2019-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10449159 2035-10-30 U-2357 2019-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10500162 2035-10-30 U-2357 2019-12-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10507186 2035-10-30 Drug product 2019-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10512612 2035-10-30 Drug product 2020-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10512613 2035-10-30 U-2357 2020-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10568841 2035-10-30 U-2357 Drug product 2020-02-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10688060 2035-10-30 Drug product 2020-06-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 9974752 2035-10-30 Drug product 2019-03-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-001 10722473 2038-11-19 U-2357 2020-07-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10111839 2035-10-30 U-2357 2019-03-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10292938 2035-10-30 Drug product 2019-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10292939 2035-10-30 U-2357 Drug product 2019-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10449159 2035-10-30 U-2357 2019-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10500162 2035-10-30 U-2357 2019-12-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10507186 2035-10-30 Drug product 2019-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10512612 2035-10-30 Drug product 2020-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10512613 2035-10-30 U-2357 2020-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10568841 2035-10-30 U-2357 Drug product 2020-02-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10688060 2035-10-30 Drug product 2020-06-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 9974752 2035-10-30 Drug product 2019-03-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-002 10722473 2038-11-19 U-2357 2020-07-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10111839 2035-10-30 U-2357 2019-03-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10292938 2035-10-30 Drug product 2019-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10292939 2035-10-30 U-2357 Drug product 2019-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10449159 2035-10-30 U-2357 2019-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10500162 2035-10-30 U-2357 2019-12-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10507186 2035-10-30 Drug product 2019-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10512612 2035-10-30 Drug product 2020-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10512613 2035-10-30 U-2357 2020-01-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10568841 2035-10-30 U-2357 Drug product 2020-02-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10688060 2035-10-30 Drug product 2020-06-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 9974752 2035-10-30 Drug product 2019-03-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-003 10722473 2038-11-19 U-2357 2020-07-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-004 10111839 2035-10-30 U-2357 2019-03-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-004 10292938 2035-10-30 Drug product 2019-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-004 10292939 2035-10-30 U-2357 Drug product 2019-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212038-004 10449159 2035-10-30 U-2357 2019-10-22 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 7 · 270 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 72912-525-30 72912052530 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72912-525-30) 2019-07-01 2023-11-01 No No Current